Cytokine & Growth Factor Reviews

Papers
(The TQCC of Cytokine & Growth Factor Reviews is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
COVID-19: From emerging variants to vaccination193
Editorial Board147
Potential effects of HMGB1 on viral replication and virus infection-induced inflammatory responses: A promising therapeutic target for virus infection-induced inflammatory diseases134
Unveiling cytokine charge disparity as a potential mechanism for immune regulation122
Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions120
Navigating IL-6: From molecular mechanisms to therapeutic breakthroughs114
Editorial Board101
Metabolic Regulation of cGAS-STING Signaling in the Tumor Microenvironment: Dual Immune Roles and Therapeutic Implications96
CDK4/6 inhibition in hormone receptor-positive/HER2-negative breast cancer: Biological and clinical aspects87
Proteomics analysis of circulating small extracellular vesicles: Focus on the contribution of EVs to tumor metabolism85
Editorial Board75
Editorial Board75
Progranulinopathy: A diverse realm of disorders linked to progranulin imbalances67
Insights into IL-6/JAK/STAT3 signaling in the tumor microenvironment: Implications for cancer therapy67
Participation of interferons in psoriatic inflammation66
Cytokine symphony: Deciphering the tumor microenvironment and metastatic axis in oral cancer61
Epithelial-to-mesenchymal transition transcription factors: New strategies for mesenchymal tissue regeneration61
Immuno-metabolic control of the balance between Th17-polarized and regulatory T-cells during HIV infection59
Natural killers or natural regulators? Dual roles of NK cells in checkpoint immunotherapy57
Molecular mechanisms of regulation of IL-1 and its receptors57
Central role of Galectin-3 at the cross-roads of cardiac inflammation and fibrosis: Implications for heart failure and transplantation56
Pro-angiogenic activity and vasculogenic mimicry in the tumor microenvironment by leptin in cancer54
TGF-β mediated drug resistance in solid cancer51
Exogenous drug-induced mouse models of atopic dermatitis44
Scarless wound healing: Current insights from the perspectives of TGF-β, KGF-1, and KGF-244
Novel insights into neuroinflammatory mechanisms in traumatic brain injury: Focus on pattern recognition receptors as therapeutic targets44
The cGAS-STING pathway: Post-translational modifications and functional implications in diseases43
Immunosuppressive tumor microenvironment and uterine fibroids: Role in collagen synthesis42
Current utilization of interferon alpha for the treatment of coronavirus disease 2019: A comprehensive review42
Chemokines and chemokine receptors: Insights from human disease and experimental models of helminthiasis42
MDSCs might be “Achilles heel” for eradicating CSCs37
Suppressor of cytokine signaling 6 in cancer development and therapy: Deciphering its emerging and suppressive roles37
Exosomes as a modulator of immune resistance in human cancers36
COVID-19 and dys-regulation of pulmonary endothelium: implications for vascular remodeling36
Tumor microenvironment, histone modifications, and myeloid-derived suppressor cells36
Multifaceted role of CD14 in innate immunity and tissue homeostasis35
Exosomes: Another intercellular lipometabolic communication mediators in digestive system neoplasms?35
Netrin-1: An emerging player in inflammatory diseases34
Modulation of IL-33/ST2 signaling as a potential new therapeutic target for cardiovascular diseases32
B cell-activating factor and its targeted therapy in autoimmune diseases32
Decoding the roles of heat shock proteins in liver cancer32
The IFN-γ/miniTrpRS signaling axis: An insight into the pathophysiology of osteoporosis and therapeutic potential32
Editorial Board31
Quantitative and qualitative differences in the activation of a fibroblast growth factor receptor by different FGF ligands30
Crosstalk between ferroptosis and the epithelial-mesenchymal transition: Implications for inflammation and cancer therapy30
Exploring inflammatory and fibrotic mechanisms driving diabetic nephropathy progression30
The roles of cell-cell and organ-organ crosstalk in the type 2 diabetes mellitus associated inflammatory microenvironment30
The impact of adipokines on vascular networks in adipose tissue29
Nuclear translocation of RON receptor tyrosine kinase. New mechanistic and functional insights29
Forgetting COVID-19 – Introduction to the special issue28
Exosomal noncoding RNA-mediated spatiotemporal regulation of lipid metabolism: Implications in immune evasion and chronic inflammation27
Liquid biopsy analysis of lipometabolic exosomes in pancreatic cancer27
Therapeutic inhibition of the JAK-STAT pathway in the treatment of inflammatory bowel disease26
The role of Extracellular Vesicles in glycolytic and lipid metabolic reprogramming of cancer cells: Consequences for drug resistance26
Extracellular vesicles: Emerging mediators of cell communication in gastrointestinal cancers exhibiting metabolic abnormalities26
Role of exosomes in transferring chemoresistance through modulation of cancer glycolytic cell metabolism25
Cholecystokinin and gastrin as immune modulating hormones: Implications and applications25
mTOR in programmed cell death and its therapeutic implications25
Nefarious NTRK oncogenic fusions in pediatric sarcomas: Too many to Trk24
Ferroptosis in immune cells: Implications for tumor immunity and cancer therapy24
Exosomes-regulated lipid metabolism in tumorigenesis and cancer progression24
Editorial Board23
The journey of STING: Guiding immune signaling through membrane trafficking23
Interleukin-17: A pleiotropic cytokine implicated in inflammatory, infectious, and malignant disorders23
Mechanisms and routes of G-protein coupled receptor-mediated Tau degradation in Alzheimer’s disease23
Glioblastoma-associated macrophages: A key target in overcoming glioblastoma therapeutic resistance23
0.088907957077026